Antimitochondrial antibodies in primary biliary cirrhosis. A clue to its etiopathogenesis?

Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens.

Clinical and experimental immunology·2003

Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity.

Journal of neuroimmunology·2002

[Autoimmune hepatitis and overlap syndrome: diagnosis].

Praxis·2002

In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.

European journal of medical research·2002

L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.

Clinical and experimental immunology·2001

Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B.

Hepato-gastroenterology·2001

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

Journal of hepatology·2026

Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

Journal of hepatology·2026

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

Journal of hepatology·2026

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

Journal of hepatology·2026

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Journal of hepatology·2026

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Journal of hepatology·2026

Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.

Journal of human immunity·2026

A Phase 2b Randomized Trial of Belimumab to Reduce Atherogenic Autoantibodies in COPD Patients.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026

Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis.

Recent advances in drug delivery and formulation·2026

Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis.

Omics : a journal of integrative biology·2026

Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review).

International journal of molecular medicine·2026

Related Experiment Videos

Antimitochondrial antibodies in primary biliary cirrhosis. A clue to its etiopathogenesis?

Related Concept Videos

Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens.

Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity.

[Autoimmune hepatitis and overlap syndrome: diagnosis].

In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.

L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.

Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B.

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.

A Phase 2b Randomized Trial of Belimumab to Reduce Atherogenic Autoantibodies in COPD Patients.

Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis.

Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis.

Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review).

Related Experiment Videos

Antimitochondrial antibodies in primary biliary cirrhosis. A clue to its etiopathogenesis?

Related Concept Videos

Related Articles